BrioHealth BV

About BrioHealth BV

BrioHealth BV is a European medical technology company developing the BrioVAD System — a fully magnetically levitated left ventricular assist device (LVAD) designed to provide long-term mechanical circulatory support for patients with advanced, refractory heart failure. Headquartered in the Netherlands, BrioHealth BV serves as the European center of operations for BrioHealth Solutions (Burlington MA, USA) and BrioHealth Technologies (Suzhou, China). Together, the BrioHealth group integrates engineering, clinical research, and regulatory expertise to advance next-generation ventricular assist technology and bring it to market. The company is committed to meeting the highest standards of quality and patient safety under the EU Medical Device Regulation (MDR) and is currently conducting a multi-center clinical investigation to evaluate the safety and performance of the BrioVAD System in patients with advanced left ventricular heart failure. Through close collaboration with clinicians, hospitals, and research partners, BrioHealth BV aims to expand access to durable mechanical circulatory support across Europe and improve outcomes for patients living with advanced heart failure. In addition to product development activities, BrioHealth BV provides marketing, sales, customer support services and post-market surveillance in accordance with applicable European regulations.